NewsFlash Archive

more Events

Subscribe

  • 0%
    0 votes

    Results From Investigator-Sponsored Trials Presented at SSIEM Conference

    Friday, September 3, 2010

    NOVATO, Calif. -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that results from investigator-sponsored studies on Kuvan (sapropterin dihydrochloride) are being presented at the 2010 Annual Symposium of the Society for The Study of Inborn Errors of Metabolism (SSIEM), August 31st-In

    read more>>

  • 0%
    0 votes

    Celldex Therapeutics Regains Worldwide Rights to Rindopepimut (CDX-110)

    Friday, September 3, 2010

    NEEDHAM, Mass. -- Celldex Therapeutics, Inc. (Nasdaq: CLDX) announced today it will regain full worldwide rights to develop and commercialize rindopepimut (CDX-110), effective November 1, 2010Celldex and Pfizer Vaccines LLC entered into a global development and commercialization agreement in April

    read more>>

  • 0%
    0 votes

    Merck Serono's Cladribine Tablets for MS Approved in Australia

    Friday, September 3, 2010

    GENEVA, Switzerland -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that the Australian Therapeutic Goods Administration (TGA) has approved Cladribine Tablets for the treatment of relapsing-remitting multiple sclerosis (MS)(1Cladribine Tablets will be registered in A

    read more>>

  • 0%
    0 votes

    Santhera and Ipsen Enter Into Licensing Agreement for Fipamezole for the Treatment of Dyskinesia in Parkinson's Disease

    Friday, September 3, 2010

    Liestal, Switzerland and Paris, France -- Santhera Pharmaceuticals (SIX: SANN) and Ipsen (Euronext: IPN; ADR: IPSEY) today announced a license agreement for the development and commercialization of fipamezole (antagonist of the adrenergic al-pha-2 receptor) for territories outside of North America

    read more>>

  • 0%
    0 votes

    Celator Pharmaceuticals Raises $20 Million in Series D Financing

    Friday, September 3, 2010

    Princeton, NJ -- Celator Pharmaceuticals, a privately held pharmaceutical company developing new and more effective therapies to treat cancer based on the company's proprietary technology, today announced that it raised $20 million in a Series D private equity financingProceeds will support comple

    read more>>

  • 0%
    0 votes

    Tot With Disorder Is 'the Happiest Kid'

    Friday, September 3, 2010

    When most people get a cold, they cough and sneeze and sniffle until it goes awayCharlie-Anne Cox can't do that. The 14-month-old's muscles are too weak to cough and the mucus drains into her lungs"Just taking a breath, that's just running a marathon for her, it sounds like at times," says her da

    read more>>

  • 0%
    0 votes

    Norfolk Baby's Life Hangs by a Thread

    Friday, September 3, 2010

    A community is rallying to fund comforts and pleasures for a seriously-ill north Norfolk baby whose life could end at any timeLittle Lauren Taylor has the rare chromosome disorder Patau's Syndrome and is blind, partially deaf, needs extra oxygen to breathe, is tube fed, has kidney problems, extra

    read more>>

  • 0%
    0 votes

    Novartis and Collaborators Discover Novel Antimalarial Drug Candidate

    Friday, September 3, 2010

    Singapore -- Novartis announced today that scientists at the Novartis Institute for Tropical Diseases (NITD), in collaboration with researchers from the Genomics Institute of the Novartis Research Foundation (GNF), the Swiss Tropical and Public Health Institute and The Scripps Research Institute M

    read more>>

  • 0%
    0 votes

    Free Prostate Screenings Offered at Virginia G. Piper Cancer Center

    Friday, September 3, 2010

    SCOTTSDALE, Ariz. -- Recognizing that early detection can save lives, the Virginia G. Piper Cancer Center at Scottsdale Healthcare is offering free prostate cancer screenings from 8:30 a.m.-12 p.m. on Saturday, Sept. 11Urologists from Scottsdale Healthcare will be available to answer questions and

    read more>>

  • 0%
    0 votes

    Goddess Hair Extensions Founder Nominated for American Cancer Society Award

    Friday, September 3, 2010

    SUNNYVALE, Calif. -- Sheila Matechuk, Developer of Goddess Hair Extensions & Replacement, has been nominated for the American Cancer Society's prestigious "Lane Adams Award" honoring individuals who "demonstrate innovative and collaborative approaches to enhancing the quality of life for Mate

    read more>>